Showing results (151-160 of 183) with videos related to

Sort By:
Pageof 19
Cancers|December 5, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine TumorsGabriel Mpilla, Amro Aboukameel, Irfana Muqbil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal AdenocarcinomaAsfar S Azmi, Husain Yar Khan, Irfana Muqbil, et al.
Cancers|April 3, 2020
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor GrowthHusain Yar Khan, Gabriel B Mpilla, Rachel Sexton, et al.
ESMO Gastrointestinal Oncology|October 1, 2025
Pharmacological advances in cannabinoid-based therapies for pancreatic cancer: preclinical efficacy of CCL-106 and its epimersK P Ray, W Cruces, Y Mzannar, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2A r and NPM1 -m AMLMd Hafiz Uddin, Sandhya Dhiman, Yufen Han, et al.
JCO Oncology Advances|May 7, 2025
Multiomic Characterization of RCC1 and RCC2 Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer OutcomesMisako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, et al.
Cancer Research Communications|May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant CancersHusain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Clinical and Translational Medicine|December 22, 2023
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse modelMd Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, et al.
JCO Precision Oncology|October 24, 2024
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis CarcinomaGianna Kroening, Jia Luo, Mark G Evans, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
Pageof 19